These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 23396042)

  • 41. Structural analysis of the catalytic and binding sites of Clostridium botulinum neurotoxin B.
    Swaminathan S; Eswaramoorthy S
    Nat Struct Biol; 2000 Aug; 7(8):693-9. PubMed ID: 10932256
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative membrane channel size and activity of botulinum neurotoxins A and E.
    Parikh S; Singh BR
    Protein J; 2007 Jan; 26(1):19-28. PubMed ID: 17216364
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structural insights into the functional role of the Hcn sub-domain of the receptor-binding domain of the botulinum neurotoxin mosaic serotype C/D.
    Zhang Y; Gardberg AS; Edwards TE; Sankaran B; Robinson H; Varnum SM; Buchko GW
    Biochimie; 2013 Jul; 95(7):1379-85. PubMed ID: 23523511
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel chimeras of botulinum neurotoxins A and E unveil contributions from the binding, translocation, and protease domains to their functional characteristics.
    Wang J; Meng J; Lawrence GW; Zurawski TH; Sasse A; Bodeker MO; Gilmore MA; Fernández-Salas E; Francis J; Steward LE; Aoki KR; Dolly JO
    J Biol Chem; 2008 Jun; 283(25):16993-7002. PubMed ID: 18400760
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Structural characterization of three novel hydroxamate-based zinc chelating inhibitors of the Clostridium botulinum serotype A neurotoxin light chain metalloprotease reveals a compact binding site resulting from 60/70 loop flexibility.
    Thompson AA; Jiao GS; Kim S; Thai A; Cregar-Hernandez L; Margosiak SA; Johnson AT; Han GW; O'Malley S; Stevens RC
    Biochemistry; 2011 May; 50(19):4019-28. PubMed ID: 21434688
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Botulinum neurotoxin: a marvel of protein design.
    Montal M
    Annu Rev Biochem; 2010; 79():591-617. PubMed ID: 20233039
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Translocation domain of botulinum neurotoxin A subtype 2 potently induces entry into neuronal cells.
    Kohda T; Tsukamoto K; Torii Y; Kozaki S; Mukamoto M
    Microbiol Immunol; 2020 Jul; 64(7):502-511. PubMed ID: 32301520
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cocrystal structure of synaptobrevin-II bound to botulinum neurotoxin type B at 2.0 A resolution.
    Hanson MA; Stevens RC
    Nat Struct Biol; 2000 Aug; 7(8):687-92. PubMed ID: 10932255
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Insights into the evolutionary origins of clostridial neurotoxins from analysis of the Clostridium botulinum strain A neurotoxin gene cluster.
    Doxey AC; Lynch MD; Müller KM; Meiering EM; McConkey BJ
    BMC Evol Biol; 2008 Nov; 8():316. PubMed ID: 19014598
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The C-terminus of botulinum neurotoxin type A light chain contributes to solubility, catalysis, and stability.
    Baldwin MR; Bradshaw M; Johnson EA; Barbieri JT
    Protein Expr Purif; 2004 Sep; 37(1):187-95. PubMed ID: 15294297
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The HCC-domain of botulinum neurotoxins A and B exhibits a singular ganglioside binding site displaying serotype specific carbohydrate interaction.
    Rummel A; Mahrhold S; Bigalke H; Binz T
    Mol Microbiol; 2004 Feb; 51(3):631-43. PubMed ID: 14731268
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular immune recognition of botulinum neurotoxin B. The light chain regions that bind human blocking antibodies from toxin-treated cervical dystonia patients. Antigenic structure of the entire BoNT/B molecule.
    Atassi MZ; Jankovic J; Steward LE; Aoki KR; Dolimbek BZ
    Immunobiology; 2012 Jan; 217(1):17-27. PubMed ID: 21962573
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Crystallographic evidence for doxorubicin binding to the receptor-binding site in Clostridium botulinum neurotoxin B.
    Eswaramoorthy S; Kumaran D; Swaminathan S
    Acta Crystallogr D Biol Crystallogr; 2001 Nov; 57(Pt 11):1743-6. PubMed ID: 11679763
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Production of recombinant botulism antigens: a review of expression systems.
    Moreira GM; Cunha CE; Salvarani FM; Gonçalves LA; Pires PS; Conceição FR; Lobato FC
    Anaerobe; 2014 Aug; 28():130-6. PubMed ID: 24930432
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mapping of the antibody-binding regions on botulinum neurotoxin H-chain domain 855-1296 with antitoxin antibodies from three host species.
    Atassi MZ; Dolimbek BZ; Hayakari M; Middlebrook JL; Whitney B; Oshima M
    J Protein Chem; 1996 Oct; 15(7):691-700. PubMed ID: 8968960
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High level expression and immunochemical characterization of botulinum neurotoxin type F light chain.
    Chauhan R; Chauhan V; Rao MK; Chaudhary D; Bhagyawant S; Dhaked RK
    Protein Expr Purif; 2018 Jun; 146():51-60. PubMed ID: 29407166
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In-Vivo Neutralization of Botulinum Neurotoxin Serotype E Using Rabbit Polyclonal Antibody Developed against BoNT/E Light Chain.
    Rani S; Ponmariappan S; Sharma A; Kamboj DV; Jain AK
    Protein Pept Lett; 2017; 24(6):495-502. PubMed ID: 28260503
    [TBL] [Abstract][Full Text] [Related]  

  • 58. TCEP treatment reduces proteolytic activity of BoNT/B in human neuronal SHSY-5Y cells.
    Shi X; Garcia GE; Neill RJ; Gordon RK
    J Cell Biochem; 2009 Aug; 107(5):1021-30. PubMed ID: 19492407
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of immune response induced against catalytic domain of botulinum neurotoxin type E.
    Sonkar P; Chauhan V; Chauhan R; Saxena N; Dhaked RK
    Sci Rep; 2020 Aug; 10(1):13932. PubMed ID: 32811892
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Crystal structure of the receptor binding domain of the botulinum C-D mosaic neurotoxin reveals potential roles of lysines 1118 and 1136 in membrane interactions.
    Zhang Y; Buchko GW; Qin L; Robinson H; Varnum SM
    Biochem Biophys Res Commun; 2011 Jan; 404(1):407-12. PubMed ID: 21130733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.